Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1 Neoplasms 1 Mesothelioma, Malignant 1 Gastrointestinal Neoplasms 1 Digestive System Neoplasms 1 Advanced Solid Tumor 1 Adenocarcinoma Gastric 1 Adenocarcinoma 1

Interventions

tusamitamab ravtansine 1 Ramucirumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Adenocarcinoma Gastric × Ramucirumab × Clear all

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated

35 enrolled 14 charts

Gastrointestinal

Adenocarcinoma Gastric

Data powered by HemOnc (CC BY 4.0) Colophon ⚡